Dr. Stephanie Berg of Dana-Farber Cancer Institute and Harvard Medical School discusses the need to be mindful of quality of life when treating prostate cancer. For providers who are treating patients ...
Dr. Stephanie Berg of the Dana-Farber Cancer Institute and Harvard Medical School discussed the recent EMARK trial which resulted in the FDA’s approval of Xtandi for non-metastatic ...
WASHINGTON (Reuters) - A mutated gene previously linked to breast cancer has been found in 70 percent of prostate tumors as well, U.S. researchers reported on Friday. They found the gene BP1 was ...
Framingham biotech company BERG released a new study revealing a new test improving diagnosis of prostate cancer, according to a Thursday press release. The study, which included 750 patients from the ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results